22 again: IL-22 as a risk gene and important mediator in psoriasis

Journal of Investigative Dermatology

Volumn 134, Issue 6, 2014, Pages 1501-1503

  Johnston, Andrew ^a   Gudjonsson, Johann E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 23; MESSENGER RNA; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 24; INTERLEUKIN 26;

BINDING SITE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; IMMUNOPATHOGENESIS; KERATINOCYTE; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PSORIASIS; REVIEW; WOUND HEALING; COPY NUMBER VARIATION; CYTOKINE RELEASE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; NATURAL KILLER CELL; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKINS; MALE; PROMOTER REGIONS, GENETIC; PSORIASIS; T-LYMPHOCYTES;

EID: 84900815328     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.81     Document Type: Note

References (12)

1. Boniface K, Bernard FX, Garcia M et al. (2005) IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174:3695-702
2. Boniface K, Guignouard E, Pedretti N et al. (2007) A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 150:407-15
3. Denison MS, Nagy SR (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43: 309-34
4. Lo YH, Torii K, Saito C et al. (2010) Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy. J Dermatol Sci 58:225-7
5. Nikamo P, Cheuk S, Lysell J et al. (2014) Genetic variants of the IL22 promoter associate to onset of psoriasis before puberty and increased IL-22 production in T Cells. J Invest Dermatol 134:1535-41
6. Ouyang W (2010) Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev 21: 435-41
7. Ramirez JM, Brembilla NC, Sorg O et al. (2010) Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 40:2450-9
8. Sa SM, Valdez PA, Wu J et al. (2007) The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178:2229-40
9. Sabat R, Ouyang W, Wolk K (2014) Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 13: 21-38
10. van den Bogaard EH, Bergboer JG, Vonk-Bergers M et al. (2013) Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. J Clin Invest 123:917-27
11. Veldhoen M, Hirota K, Westendorf AM et al. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453:106-9
12. Wolk K, Witte E, Wallace E et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36:1309-23